Medicare billing address
CMS Medicare provider billing file
3860 Jackson Ave Ste 2Ogden, UT 84403
CMS public data · NPI 1487672986
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
David M Allen, MD
Specialty
Credential
MD
NPI
1487672986
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for David M Allen, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
3860 Jackson Ave Ste 2CMS Doctors & Clinicians file
4650 Harrison BlvdIn the 2024 CMS provider billing file, this NPI had 893 Medicare beneficiaries and 6,541 total services. The average beneficiary age was 76, and the average HCC risk score was 1.1.
Total Medicare allowed amount
$334,090.40
Total Medicare payment amount
$229,035.69
Medicare beneficiaries
893
Total services
6,541
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
66%
CMS beneficiary-panel share
Hypertension
62%
CMS beneficiary-panel share
Chronic kidney disease
28%
CMS beneficiary-panel share
Diabetes
25%
CMS beneficiary-panel share
Ischemic heart disease
25%
CMS beneficiary-panel share
Mood disorders
22%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 2,743 | $6.44 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 1,066 | $89.19 |
| Destruction of precancer skin growth, 1 growth | 1,040 | $56.72 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 535 | $126.28 |
| Biopsy of related skin growth, first growth | 245 | $89.77 |
| Destruction of skin growth, 1-14 growths | 107 | $104.17 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 76 | $16.39 |
| New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 54 | $108.61 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 42 | $133.40 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 33 | $165.31 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1487672986. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Triamcinolone Acetonide | Triamcinolone Acetonide | 407 | 471.3 | $4,782.93 |
| 2 | Ketoconazole | Ketoconazole | 210 | 236.5 | $3,285.86 |
| 3 | Fluorouracil | Fluorouracil | 129 | 132.1 | $10,559.34 |
| 4 | Clindamycin Phosphate | Clindamycin Phosphate | 122 | 137.5 | $3,859.57 |
| 5 | Fluocinonide | Fluocinonide | 99 | 104 | $5,040.19 |
| 6 | Desonide | Desonide | 69 | 72 | $4,023.54 |
| 7 | Clobetasol Propionate | Clobetasol Propionate | 67 | 69.6 | $5,027.47 |
| 8 | Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 66 | 108.3 | $770.21 |
| 9 | Metronidazole | Metronidazole | 66 | 69 | $3,230.16 |
| 10 | Valacyclovir | Valacyclovir Hcl | 49 | 56.8 | $995.76 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Medical College Of Wisconsin
Graduation year
1999
Group/practice field
Ogden Clinic Specialty Services Llc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.